Font Size:
a
A
A
Keyword [Treatment-resistant]
Result: 41 - 58 | Page: 3 of 3
41.
Part One. The pharmacogenetics of treatment resistant depression. Part Two. DNA interaction and photocleavage by di- and tetracationic intercalants
42.
Psychological flexibility, rumination, and avoidance as predictors of outcome in cognitive behavioral therapy for treatment-resistant major depressive disorde
43.
Using network analysis to identify factors differentiating antipsychotic treatment-resistant and treatment-responsive patients with psychosis
44.
Bortezomib For The Intervention Of Treatment-resistant Anti-NMDAR Encephalitis
45.
The Clinical And Brain Mechanism Study Of Transcutaneous Auricular Vagus Nerve Stimulation For Treating The Treatment Resistant Depression Using BOLD/MRS Multimodal FMRI
46.
Magnetic Seizure Therapy And Electroconvulsive Therapy For Ultra-treatment-resistant Schizophrenia: A Parallel Control Pilot Study
47.
The Level Of Baseline Cognition And Early Clinical Improvement Of Treatment Resistant Depression Predict The Therapeutic Outcome Of Electroconvulsive Therapy
48.
Study Of Plasma Non-enzyme Antioxidants And Thyroid Hormone Levels And Cognitive Levels In Patients With Treatment-resistant Depression
49.
Resting State Functional Magnetic Resonance Imaging Of Treatment-resistant Depression Before And After Electroconvulsive Therapy Based On ReHo And FC
50.
Therapeutic Effects And Brain Functional Mechanisms Of Nitrous Oxide On Patients With Treatment-resistant Depression
51.
A Voxel-Based Morphometry Study Of Patients With Treatment-Resistant Depression Before And After Electroconvulsive Therapy
52.
Characteristics Of Clinical Pathology And Cognitive Impairment In Treatment Resistant Patients With Schizophrenia
53.
Efficacy And Safety Of Electroacupuncture Combined With LF-rTMS In The Treatment Of Treatment Resisdant Depression
54.
The Role And Mechanism Of High Mobility Group Box 1 In Cortical Dysplasia-associated Epilepsy
55.
Prevalence And Influencing Factors Of Apparent Treatment-Resistant Hypertension In Patient With Peritoneal Dialysis
56.
The Study Of Glutamate Receptor Antibody Levels In Treatment Resistant Schizophrenia
57.
Dual-target Accelerated RTMS For Treatment-resistant Depression Study On The Effect Of Curative Effect And Resting-state Functional Connection
58.
Network Meta-analysis Of Escitalopram Combined With Other Drugs In The Treatment Of Refractory Depressio
<<First
<Prev
Next>
Last>>
Jump to